This page is part of the International Patient Summary Implementation Guide (v0.3.0: STU 1 Ballot 3) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
JSON Format: ValueSet-med-uv-ips
Download Raw json
{
"resourceType" : "ValueSet",
"id" : "med-uv-ips",
"meta" : {
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">This value set provides an example of possible coded concepts representing:\n\t\t<ul>\n\t\t\t\t<li>medicinal products;</li>\n\t\t\t\t<li>packaged medicinal products; </li>\n\t\t\t\t<li>or medications based on:\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t<li>their generic composition of active substance(s) This is what usually identifies IDMP PhPID Active Substance Stratum Level 1);</li>\n\t\t\t\t\t\t<li>their generic composition of active substance(s) with strength. This is what usually identifies IDMP PhPID Active Substance Stratum Level 2.</li>\n\t\t\t\t\t\t<li>their generic composition of active substance(s) with administrable dose form. This is what usually identifies PhPID Active Substance Stratum Level 3.</li>\n\t\t\t\t\t\t<li>their generic composition of active substance(s) with strength and administrable dose form. This is what usually identifies PhPID Active Substance Stratum Level 4.</li>\n\t\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\t\t\t<b>Please note that this Value set is not representing any IDMP identifier</b>. It is envisioned that future version will be based on the IDMP IDs when available for actual use.</div>"
},
"url" : "http://hl7.org/fhir/uv/ips/ValueSet/med-uv-ips",
"version" : "0.3.0",
"name" : "MedicationCodesUvIps",
"title" : "Medications (example)",
"status" : "draft",
"experimental" : true,
"date" : "2019-08-06T10:41:01-04:00",
"publisher" : "HL7 International",
"contact" : [
{
"name" : "HL7 International",
"telecom" : [
{
"system" : "phone",
"value" : "+1 734 677 7777"
},
{
"system" : "fax",
"value" : "+1 734 677 6622"
},
{
"system" : "email",
"value" : "info@hl7.org"
}
]
}
],
"description" : "This value set provides an example of possible coded concepts representing medicinal products, packaged medicinal products, or medications based on their generic composition of active substance(s); active substance(s) with strength; active substance(s) with administrable dose form; active substance(s) with strength and administrable dose form.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"immutable" : false,
"compose" : {
"include" : [
{
"system" : "http://snomed.info/sct",
"concept" : [
{
"code" : "777067000",
"display" : "Acetaminophen only product"
},
{
"code" : "774587000",
"display" : "Amoxicillin and clavulanic acid only product"
},
{
"code" : "776556004",
"display" : "Lithium citrate only product"
},
{
"code" : "774409003",
"display" : "Acenocoumarol only product"
},
{
"code" : "780130002",
"display" : "Acetaminophen only product in rectal dose form"
},
{
"code" : "778315007",
"display" : "Amoxicillin and clavulanic acid only product in oral dose form"
},
{
"code" : "779725005",
"display" : "Lithium citrate only product in oral dose form"
},
{
"code" : "778207007",
"display" : "Acenocoumarol only product in oral dose form"
},
{
"code" : "322257001",
"display" : "Paracetamol 250 mg rectal suppository"
},
{
"code" : "392259005",
"display" : "Amoxicillin 875 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet"
},
{
"code" : "766489003",
"display" : "Lithium citrate 104 mg/mL oral solution"
},
{
"code" : "319740004",
"display" : "Acenocoumarol 1 mg oral tablet"
}
]
}
]
}
}
